Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...
CVS Caremark and Optum disputed the FTC's allegations. "CVS Caremark is proud of the work we have done to make insulin more affordable for all Americans with diabetes. To suggest anything ...
The FTC did not sue the three major makers of ... The drugmaker’s shares did not react on Friday afternoon. CVS Caremark said in its statement that any attempt to curtail pharmacy benefit ...